252 results on '"El-Rifai, Wael"'
Search Results
2. Fibroblast growth factor receptor-4 mediates activation of Nuclear Factor Erythroid 2-Related Factor-2 in gastric tumorigenesis
3. Chronic Gastroesophageal Reflux Dysregulates Proteostasis in Esophageal Epithelial Cells
4. Correction: Activation of IGF1R by DARPP-32 promotes STAT3 signaling in gastric cancer cells
5. Smoking induces WEE1 expression to promote docetaxel resistance in esophageal adenocarcinoma
6. SOX9 Modulates the Transformation of Gastric Stem Cells Through Biased Symmetric Cell Division
7. Protein adduction causes non-mutational inhibition of p53 tumor suppressor
8. CDK1 bridges NF-κB and β-catenin signaling in response to H. pylori infection in gastric tumorigenesis
9. Induction of Fibroblast Growth Factor Receptor 4 by Helicobacter pylori via Signal Transducer and Activator of Transcription 3 With a Feedforward Activation Loop Involving SRC Signaling in Gastric Cancer
10. Helicobacter pylori–induced RASAL2 Through Activation of Nuclear Factor-κB Promotes Gastric Tumorigenesis via β-catenin Signaling Axis
11. miRNAs as novel immunoregulators in cancer
12. Esophageal adenocarcinoma models: a closer look.
13. A novel strategy for combination of clofarabine and pictilisib is synergistic in gastric cancer
14. Integration of CRISPR/Cas9 with artificial intelligence for improved cancer therapeutics
15. APE1 redox function is required for activation of Yes-associated protein 1 under reflux conditions in Barrett’s-associated esophageal adenocarcinomas
16. Liquid biopsy: a step closer to transform diagnosis, prognosis and future of cancer treatments
17. Data from Targeting SMAD3 Improves Response to Oxaliplatin in Esophageal Adenocarcinoma Models by Impeding DNA Repair
18. Targeting SMAD3 Improves Response to Oxaliplatin in Esophageal Adenocarcinoma Models by Impeding DNA Repair
19. NF-kB-dependent activation of STAT3 by H. pylori is suppressed by TFF1
20. Cytokine-chemokine network driven metastasis in esophageal cancer; promising avenue for targeted therapy
21. Tumor microenvironment: an evil nexus promoting aggressive head and neck squamous cell carcinoma and avenue for targeted therapy
22. Correction: Tumor microenvironment: an evil nexus promoting aggressive head and neck squamous cell carcinoma and avenue for targeted therapy
23. Correction: Activation of IGF1R by DARPP-32 promotes STAT3 signaling in gastric cancer cells
24. Fibroblast growth factor receptor-4 mediates activation of Nuclear Factor Erythroid 2-Related Factor-2 in gastric tumorigenesis
25. Reflux conditions induce E-cadherin cleavage and EMT via APE1 redox function in oesophageal adenocarcinoma.
26. Abstract 1379 CDK1-SOX9 axis contributes to chemotherapy resistance in gastric cancer
27. Abstract 3237: Dovitinib restricts EMT and promotes T cell recruitment to immune-desert gastric cancers via tumor-intrinsic IFN-γ signaling
28. Abstract 3964: APE1 protects SMAD3 against ROC1 ubiquitin mediated degradation in esophageal adenocarcinoma cells
29. Abstract 4776: NRF2 is overexpressed in esophageal adenocarcinoma and its targeting sensitizes tumor cells to cisplatin through induction of ferroptosis and apoptosis
30. Abstract 2592: Helicobacter pylori-induced FGFR4 mediates nuclear accumulation of NRF2 in gastric tumorigenesis
31. Abstract 1232: Gastroesophageal reflux disease promotes E-cadherin cleavage and activates EMT via APE1-redox function in esophageal adenocarcinoma
32. Abstract 5972: CDK1 bridges NF-kB and b-catenin signaling in response to H. pylori infection in gastric tumorigenesis
33. Data from Methylation of the HOXA10 Promoter Directs miR-196b-5p–Dependent Cell Proliferation and Invasion of Gastric Cancer Cells
34. Supplementary Table 1 from The Aurora Kinase A Inhibitor MLN8237 Enhances Cisplatin-Induced Cell Death in Esophageal Adenocarcinoma Cells
35. Supplementary Figure Legends 1-3, Table Legend 1 from The Aurora Kinase A Inhibitor MLN8237 Enhances Cisplatin-Induced Cell Death in Esophageal Adenocarcinoma Cells
36. Supplementary Figure 2 from The Aurora Kinase A Inhibitor MLN8237 Enhances Cisplatin-Induced Cell Death in Esophageal Adenocarcinoma Cells
37. Supplementary Figure 1 from Methylation of the HOXA10 Promoter Directs miR-196b-5p–Dependent Cell Proliferation and Invasion of Gastric Cancer Cells
38. Reflux conditions induce E-cadherin cleavage and EMT via APE1 redox function in oesophageal adenocarcinoma
39. Multivalent tyrosine kinase inhibition promotes T cell recruitment to immune-desert gastric cancers by restricting epithelial-mesenchymal transition via tumour-intrinsic IFN-γ?signalling.
40. Urgent need to mitigate disparities in federal funding for cancer research.
41. Supplementary Figure S1. from DNA Methylation Predicts Progression of Human Gastric Lesions
42. Supp Figure S11 from A Combination of SAHA and Quinacrine Is Effective in Inducing Cancer Cell Death in Upper Gastrointestinal Cancers
43. Supplementary Figure 1 from HDM2 Regulation by AURKA Promotes Cell Survival in Gastric Cancer
44. Supp Table 1 from A Combination of SAHA and Quinacrine Is Effective in Inducing Cancer Cell Death in Upper Gastrointestinal Cancers
45. Supplementary Figure S3 from Activation of EIF4E by Aurora Kinase A Depicts a Novel Druggable Axis in Everolimus-Resistant Cancer Cells
46. Supplementary Table S1. from DNA Methylation Predicts Progression of Human Gastric Lesions
47. Supplementary Figure Legend from Resistance to TRAIL Is Mediated by DARPP-32 in Gastric Cancer
48. Supplementary Table S1 from Activation of EIF4E by Aurora Kinase A Depicts a Novel Druggable Axis in Everolimus-Resistant Cancer Cells
49. Supplementary Figure 6 from HDM2 Regulation by AURKA Promotes Cell Survival in Gastric Cancer
50. Supplementary Figures 1 - 2, Table 1 from Antitumor Activity of Cell-Permeable RUNX3 Protein in Gastric Cancer Cells
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.